Menu ×


Osteoarthritis Treatment Market Segmentation by Drug Class (Analgesics, Nonsteroidal, Anti-Inflammatory Drugs, Corticosteroids, Hyaluronic Acid, and Phase III Drugs); by Route of Administration (Oral, and Parenteral); by Diseases Type (Ankle, Hip, Knee, Shoulder Osteoarthritis, and Others); and by Distribution Channel (Hospital, Retail, and Online Pharmacies) – Global Demand Analysis & Opportunity Outlook 2031

  • Report ID: 195
  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • May 20, 2022: Pfizer Inc. joins hand with NetVation DL Medicine which is a privately held biotechnology company based in Chengdu.

  • April 28, 2022: Medtronic plc (MDT), a medical technology company, announced collaboration with GE to meet growing need for outpatient care.  

Global Osteoarthritis Treatment Market Highlights Over 2022 - 2031

The global osteoarthritis treatment market is estimated to garner a notable CAGR over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the increased number of patients with osteoarthritis. Osteoarthritis is a type of arthritis that occurs when flexible tissue at the ends of bone wears down. The main factor for the rise of osteoarthritis is the increasing number of geriatric population. According to the report published by United Nations, there were 703 million people aged 65 years or over in the world in 2019. Hence on the back of the increasing geriatric population, the global osteoarthritis treatment market is estimated to witness remarkable growth during the forecast period. Moreover, the World Obesity Atlas 2022 report published by the World Obesity Federation predicts that 1 billion people globally, including 1 in 7 men and 1 in 5 women will be living with obesity by 2030. Obesity is also a primary factor that contributes to the development of osteoarthritis. The excess weight adds pressure and stress on joint, and fat cells promote inflammation. Additionally, osteoarthritis is also caused by joint injuries such as bone fracture, cartilage, or ligament tear. Posttraumatic osteoarthritis is the occurrence of arthritis after a trauma or an accident. The condition is becoming common and it is estimated that approximately 10% of osteoarthritis cases of the knee, ankle, and hip are the result of trauma or accident. Owing to surging accidental cases the global osteoarthritis treatment market is expected to grow during the forecast period.

Osteoarthritis Treatment Market

Get more information on this report: Download Sample PDF

The market is segmented by distribution channel into hospital, retail, and online pharmacies. Out of which, the hospital sub-segment is anticipated to hold the largest share in the global osteoarthritis treatment market during the forecast period on account of a large number of patients getting admitted to the hospitals. As hospitals are equipped with ultra-modern machines and talented doctors, plenty of patients are seeking treatment in the hospitals.

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Global Osteoarthritis Treatment Market Regional Synopsis

Regionally, the global osteoarthritis treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to witness modest growth over the forecast period on the back of the presence of ultra-modern healthcare infrastructure in the region. According to the data released by the Centers for Diseases Control and Prevention, osteoarthritis affects over 32.5 million US adults. On the back of rising cases of osteoarthritis in the USA, patients are looking for effective measures of relief. This is estimated to propel the global osteoarthritis treatment market growth during the forecast period.

The global osteoarthritis treatment market is also projected to grow outstandingly during the forecast period in the Asia Pacific region. The region is highly populous and has a large number of osteoarthritis patients. The data released by the National Institute of Health and Family Welfare (NIHFW) in 2017, osteoarthritis is the 2nd most common rheumatologic problem in India, and 70% of the people above 65 years show radiological evidence of osteoarthritis. Owing to this, the global osteoarthritis treatment market growth is predicted to propel during the forecast period.

Osteoarthritis Treatment Market Share

Get more information on this report: Download Sample PDF

The global osteoarthritis treatment market is further classified on the basis of region as follows: 

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook 

  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 

  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook 

  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook 

Market Segmentation 

Our in-depth analysis of the global osteoarthritis treatment market includes the following segments:  

By Drug Class 

  • Analgesics
  • Nonsteroidal
  • Anti-Inflammatory Drugs
  • Corticosteroids
  • Hyaluronic Acid
  • Phase III Drugs 

By Route of Administration

  • Oral
  • Parenteral 

By Diseases Type  

  • Ankle Osteoarthritis
  • Hip Osteoarthritis
  • Knee Osteoarthritis
  • Shoulder Osteoarthritis
  • Others

By Distribution Channel

  • Hospital
  • Retail
  • Online Pharmacies

Growth Drivers  

  • Increasing Patients with Osteoarthritis
  • Growing Government Initiatives Worldwide


  • Lack of Awareness among People

Top Featured Companies Dominating the Market 

  • Sanofi-aventis Groupe
    • Company Overview 
    • Business Strategy 
    • Key Product Offerings 
    • Financial Performance 
    • Key Performance Indicators 
    • Risk Analysis 
    • Recent Development 
    • Regional Presence 
    • SWOT Analysis 
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Bayer AG
  • Zimmer Biomet Holdings, Inc.
  • Horizon Therapeutics plc
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Ferring Group
  • Merck & Co., Inc


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions | LOB

Copyright © 2022 Research Nester. All Rights Reserved